Ftse Mib
34.418,62
0,30%
DAX
20.304,42
0,25%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
105.172,52
-0,92%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Rakovina Therapeutics Inc (RKV) Rakovina Therapeutics Inc (RKV) Notizie

Rakovina Therapeutics Inc

RKV
0,13
0,00 (0,00%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
18/12/202403:55GLOBERakovina Announces Debentureholder Election to Receive..
14/12/202400:50GLOBERakovina Therapeutics Announces Closing of Oversubscribed..
03/12/202413:35GLOBERakovina Therapeutics Announces Presentation at the 13th..
03/12/202400:22GLOBERakovina Therapeutics Increases Private Placement Offering..
30/11/202402:40GLOBERakovina Therapeutics Announces 2024 Q3 Financial Results..
29/11/202405:00GLOBERakovina Therapeutics Announces Increase in Private..
28/11/202403:33GLOBERakovina Therapeutics Announces Private Placement Offering
25/11/202413:30GLOBERakovina Therapeutics Presents AI-Driven Drug Discovery..
20/11/202422:30GLOBERakovina Therapeutics Announces Upcoming Poster Presentation..
25/10/202413:30GLOBERakovina Therapeutics to Present Research Highlighting..
23/10/202413:30GLOBERakovina Therapeutics Announces Initial Drug Candidates from..
17/9/202423:01APSTargeting Cancer's Achilles Heel: AI-Driven DDR Therapies..
17/9/202413:30GLOBERakovina Therapeutics and Variational AI Announce Drug..
11/9/202400:53APSJunior Biotech Utilizes AI To Shorten Drug Discovery..
30/8/202422:10GLOBERakovina Therapeutics Announces 2024 Q2 Financial..
27/7/202403:25GLOBERakovina Therapeutics Closes Previously Announced..
23/7/202403:55GLOBERakovina Therapeutics Provides Update on Previously..
19/7/202415:47GLOBERakovina Therapeutics Announces Second Upsizing of Private..
20/6/202423:34GLOBERakovina Therapeutics Announces Oversubscribed Private..
30/5/202423:52GLOBERakovina Therapeutics Announces 2024 Q1 Financial Results..
24/5/202422:30GLOBERakovina Therapeutics Announces Debentureholder Election to..
23/5/202413:30GLOBERakovina Therapeutics Announces $1.5 million Non-Brokered..
08/5/202414:00GLOBERakovina Therapeutics Announces Extensions and Expansions of..
27/4/202402:38GLOBERakovina Therapeutics Inc. Announces 2023 Financial Results..
09/4/202422:05GLOBERakovina Therapeutics Presented at American Association of..
01/4/202413:15GLOBERakovina Therapeutics To Host Informational Webinar on April..
27/3/202421:05GLOBERakovina Therapeutics Announces Strategic Pivot to AI
Apertura: Min: Max:
Chiusura: 0,13

La tua Cronologia

TSXV
RKV
Rakovina Therapeutics
EU
SCHPA
SCHP 2.9% until 05/22/2026
LSE
96PZ
Res.mort.10'b's
LSE
41BF
Hsbc Bk. 24
BIT
I06748
Intesa Sanpaolo
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network